Our company is founded and led by pioneers in Treg biology and cell therapy.
At SonomaBio we believe in balance.
Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat autoimmune and inflammatory diseases by restoring balance to the immune system.
Founded by pioneers in Treg biology and cell therapy, we are employing proprietary platform technologies and approaches to develop a new generation of targeted and durable Treg cell therapies with the potential to cure autoimmune and inflammatory diseases.
Founding Story
Values In Action
Our guiding principles inform what we do and how we do it.
Who We Are
Meet the SonomaBio team.
